Centre Hospitalier Et Universitaire De Limoges — Clinical Trial Site

408 Registered trials

199 Currently recruiting

Organisation

Centre Hospitalier Et Universitaire De Limoges

Location

Limoges, France

Identifier

ORG-100009390

Address

2 Avenue Martin Luther King, 87042, France

Departments

#1218: Neurology
#1710:Rhumatology
#3310:Intensive care Unit
#5010: Hématologie Clinique et Thérapie cellulaire
033004:oncology
1218: Hématologie Clinique et Thérapie cellulaire
125009: Hématologie Clinique et Thérapie cellulaire
1817 :Rhumatologie
1817:Rheumatology
2106 Rheumatology
213:Hématologie Clinique et Thérapie cellulaire
2304: Département de pneumologie UOT
2310:Département de Cardiologie
2403:Service de Pneumologie, Oncologie Thoracique et Pneumologie Interventionnelle
7019:Neurology
87
87042
Anesthesia
Cardiologie
Centre d'Investigation Clinique 1435
Centre d’investigation Clinique
Centre de Référence des Maladies Neuromusculaires
Centre de référence Sclérose Latérale Amyotrophique (SLA) et autres maladies du motoneurone
Centre national de référence des Herpes virus
Chest Oncology
Chest Oncology Unit
Chir Dig
Chirurgie pédiatrique
Chirurgie digestive générale et endocrinienne
Chirurgie infantile
Chirurgie thoracique
chirurgie viscérale pédiatrique
Chronic Pain Center
CHU Dupuytren
CHU Dupuytren - Unite d'Oncologie Thoracique et Cutanee (UOTC)
CHU Dupuytren 1 - Médecine interne
CHU Dupuytren 1 - Service d’Hématologie Clinique et Thérapie Cellulaire
CHU Dupuytren 1 - Unité Oncologie Thoracique et Cutanée (UOTC)
Clinical Hematology
Clinical Hematology and cell therapy
Clinical Hematology and Cellular Therapy
Clinical Hematology and Cellular Therapy Department
Département d'urgences
Département d’Hématologie
Département d’oncologie
Département d’oncologie médicale
Département d’Oncologie thoracique
Departement de Cardiologie
Département de Neurologie
Département de Neurologie et CIC
Département de pneumologie
Département des Maladies Respiratoires
Department of Clinical Hematology and Cell Therapy
Dermatology
Digestive oncology
Digestive surgery
Dupuytren 1
Emergency Department
Endocrinologie - Diabétologie - Maladies métaboliques et Médecine de la reproduction
FR032A: Hematologie Clinique et Therapie cellulaire
FR10025: Hématologie Clinique et Thérapie cellulaire
FR30013 Hématologie Clinique et Thérapie cellulaire
Gastroentérologie
gastroenterology
Geriatric Medicine
Gérontologie clinique
Gynecological surgery
haemato-oncology paediatric
Haematology
Hématologie
Hématologie Clinique
Hématologie clinique et Thérapie cellulaire
Hématologie et Cancérologie pédiatrique
Hématologie et thérapie cellulaire
Hématologie pédiatrique
Hématologie-oncologie Pédiatrique
Hematology
Hematology and celle therapy
Hematology and cellular therapy
Hematology Department
Hépato Gastroentérologie
Hépato-gastro- entérologie
Hépato-Gastro-Entérologie
Hepato-Gastro-Enterology
Hepato-gastro-enterology department
Hepato-Gastro-Enterology department
Hepato-Gastro-Enterology, Hopital Dupuytren 1
Hépato-Gastroentérologie
Hepato-gastroenterology
Hepato-gastroentorology
Hepatogastroenterology
Hôpital Dupuytren
Hôpital Dupuytren - Service d'hématologie clinique et thérapie cellulaire
Hôpital Dupuytren - Service de médecine gériatrique
Hopital Dupuytren 1 - Service Hepato-Gastroenterologie et Nutrition
HOPITAL DUPUYTREN 1 - Unité d'Oncologie Thoracique et Cutanée (UOTC)
ICU
Infectious and Tropical Diseases
intensive care
Intensive Care Unit
Internal Medicine
Maxillofacial surgery
Médecine Intensive
Médecine Interne
Médecine Interne A
Médecine respiratoire
Médecine Vasculaire
Medical Intensive Care Unit
Medical oncology
medical oncology and reproductive medicine
Multipurpose intensive care
N/A
Neonatology
Néphrologie et Transplantation
Nephrology
Neurologie
Neurology
Neurology Department
Neuroradiologie
Neurradiologie
Onco-hématologie pédiatrique
Onco-pneumology
Oncolgie
oncologic
Oncologic department
ONCOLOGIE
Oncologie hématologie et thérapie cellulaire
Oncologie médicale
Oncologie Thoracique et Cutanée
Oncologue
Oncology
Oncology department
Oncology for pediatrics
Oncology radiotherapy
Oncology thoracic Unit
Orthopedic surgery
Paediatric haematology oncology
Pédiatrie chirurgie viscérale
Pédiatrie médicale
Pneumologie
Pneumologie et allergologie pédiatrqiues
Pneumologie et d'allergologie
Pneumologie, Oncologie Thoracique et Pneumologie Interventionnelle
Pneumology
Pneumology Oncology
Pneumology Thoracic Oncology Unit
Pneumology UOT
Pneumology, Thoracic Oncology and Interventional Pneumology
Radiotherapy
Réanimation polyvalente
Rheumatology
Rhumatologie
Service d'hématologie clinique
Service d'hématologie clinique et thérapie cellulaire
Service d'Hématologie clinique et Thérapie Celulaire
Service d'Onco-Hématologie
Service d'Oncologie
Service d'oncologie hématologie et thérapie cellulaire
Service d'oncologie médicale
Service d’Hématologie
Service d’Hématologie clinique et de thérapie cellulaire
Service d’Hématologie Clinique du Pr. Marolleau
Service d’Hématologie Clinique et Thérapie Cellulaire
Service d’Hématologie Clinique et Thérapie Cellulaire
Service d’hématologie et d’oncologie pédiatrique
Service d’Oncologie
Service d’oncologie médicale
Service de Pneumologie, Oncologie thoracique et Pneumologie Interventionnelle
Service de Cardiologie
Service de chirurgie vasculaire et médecine vasculaire
Service de hémato et oncologie pédiatrique
Service de Maladies Infectieuses et Tropicales
Service de Médecine Gériatrique
Service de Néphrologie
Service de Néphrologie [Nephrology department]
Service de Néphrologie et Transplantation
Service de Neurologie
Service de Pneumologie
Service de Pneumologie, Oncologie thoracique et Pneumologie Interventionnelle
Service de réanimation polyvalente
Service des Maladies Respiratoires
Service des Urgences
Service hématologie clinique et thérapie cellulaire
Service Hépato-gastro- entérologie
Service Hépato-Gastroenterologie et nutrition
service Hépato-Gatroentérologie
Service Oncologie Medicale
SMIT
Surgery
Unité d'oncologie thoracique et cutané
Unité d'Oncologie Thoracique et Cutanée
Unité d’Onco-Hématologie Pédiatrique
Unité d’Oncologie Thoracique
Unité d’Oncologie Thoracique et Cutanée
UNITE ONCOLOGIE THORACIQUE CUTANEE
Urgences pédiatriques
Urological and andrological surgery
Urologie
Vascular

Clinical trials at this site (408)

Search interface

OASIS II - A randomized phase II trial evaluating Ibrutinib plus CD20 Ab and Ibrutinib-Venetoclax plus CD20 Ab in patients with untreated ma… Ended

2024-512634-15-00 Patients with untreated mantle cell lymphoma 9 2022-01-05
VERLEN - Phase II, Open-Label Study evaluating efficacy of Lenalidomide and Tafasitamab combination associated to Rituximab in frontline Dif… Ended

2023-507286-25-00 Diffuse Large B-Cell Lymphoma 4 2021-12-23
A clinical study to assess the efficacy and safety of lanifibranor followed by an active treatment extension in adult patients with non-cirr… Ended

2023-508248-23-00 Non-alcoholic steatohepatitis (NASH) 5 2021-11-26
A research study to find out whether a medicine called inclisiran helps to prevent cardiovascular death, heart attacks or strokes in people … Ended

2024-510735-21-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2021-11-26
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC (Tec-Dara) versus Daratumumab SC, Pomalidomide, and Dexa… Ended

2023-503441-55-00 Relapsed/Refractory Multiple Myeloma 4 2021-10-14
A Phase 3 Trial of Fixed Duration Pirtobrutinib (LOXO-305) plus Venetoclax and Rituximab versus Venetoclax and Rituximab in Previously Treat… Ended

2023-507698-16-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2021-10-14
A randomized, double-blind, Phase III Study of AZD9833 plus CDK4/6 inhibitor in patients with metastatic breast cancer with detectable ESR1 … Ended

2023-503990-39-00 Estrogen Receptor-Positive, HER-2 negative Advanced Bre 5 2021-09-30
MagnetisMM-5: A Phase 3 Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dex… Ended

2023-509208-14-00 MULTIPLE MYELOMA 5 2021-09-28
Evaluation of two maintenance therapies (OSE2101 alone or in combination with pembrolizumab) versus best supportive care in patient with pla… Ended

2024-516096-32-00 Platinum sensitive recurrent ovarian cancer 4 2021-08-05
Study of Subcutaneous Pembrolizumab versus Intravenous Pembrolizumab, Given with Chemotherapy, to Treat Metastatic Squamous or Non Squamous … Ended

2023-508308-40-00 Metastatic (stage IV) squamous or nonsquamous non-small 5 2021-07-30
Phase Ib/III Study of Capivasertib + CDK4/6 Inhibitors + Fulvestrant as Treatment for Advanced/Metastatic HR+/HER2-Breast Cancer (CAPItello-… Ended

2023-504997-39-00 Hormone Receptor-Positive and Human Epidermal Growth Fa 5 2021-06-14
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants with Early Parkinson's Disease Ended

2023-507132-21-00 Early Parkinson's disease 10 2021-05-11
Phase 3 Trial of Perioperative EV and Pembro vs. Chemo in Cis-E MIBC Ended

2023-505615-21-00 Muscle Invasive Bladder Cancer 5 2021-04-28
A study comparing current available therapies with imetelstat for the treatment of intermediate-2 or high-risk MF who are not responding to … Ended

2023-509120-17-00 Myelofibrosis 5 2021-04-12
Please refer to the full title. Ended

2024-516549-37-00 Treatment of Parkinson’s disease (PD) 4 2021-04-12
Double blind, multicentric, randomized, placebo-controlled trial, evaluating the efficacy of 24-month of bezafibrate in primary sclerosing c… Ended

2024-511658-28-01 primary sclerosing cholangitis 5 2021-04-06
A double-blind study to evaluate the effectiveness and safety of CAEL-101 in patients with AL amyloidosis. Ended

2022-503072-84-00 stage IIIa cardiac AL amyloidosis 5 2021-02-13
A double-blind study to evaluate the effectiveness and safety of CAEL-101 in patients with AL amyloidosis Ended

2022-503073-11-00 Stage IIIb cardiac AL amyloidosis 5 2021-02-13
FIBRAPLO - Haplo-identical transplantation in patients with myleofibrosis Ended

2024-513325-23-00 Myelofibrosis 4 2021-02-03
KILT - A RANDOMIZED NON COMPARATIVE PHASE II STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX ALONE IN RELAPSED/REFRACTORY PATIENTS WITH PERIPHERA… Ended

2024-513252-15-00 IN RELAPSED/REFRACTORY PATIENTS WITH PERIPHERAL T-CELL 4 2021-01-28
Encorafenib in combination with Binimetinib in Patients with BRAFV600E mutant metastatic Lung Cancer Ended

2024-515944-22-00 BRAFV600E-mutant metastatic Non-small Cell Lung Cancer 4 2021-01-19
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation Ended

2023-507263-19-00 Advanced Non-Small Cell Lung Cancer 5 2020-12-23
Brentuximab Vedotin plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL Ended

2023-503384-41-00 Relapsed or refractory diffuse large B-cell lymphoma (D 5 2020-12-22
A Phase 3 Trial of Epcoritamab vs Investigator’s Choice Chemotherapy in R/R DLBCL Ended

2023-504830-23-00 B-cell Lymphoma 5 2020-12-16